Log in
Enquire now

List of SBIR/STTR awards granted to Orphagen Pharmaceuticals

List of SBIR/STTR awards granted to Orphagen Pharmaceuticals
List of SBIR/STTR awards granted to Sonovol, Inc.
List of SBIR/STTR awards granted to BENEFICIAL DESIGNS INC
List of SBIR/STTR awards granted to LITHOLINK CORPORATION
Companies in the Restaurant industry
Companies in the Robot-enabled delivery industry
where
SBIR/STTR Award Recipient
is
Orphagen PharmaceuticalsOrphagen Pharmaceuticals
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase II Award, July 2021

A SBIR Phase II contract was awarded to Orphagen Pharmaceuticals in July, 2021 for $1,306,362.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
National Institutes of Health
National Institutes of Health
SBIR
1R44CA265639-01
Phase II
1,306,362
July 5, 2021
sbir.gov/node/2191457
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase II Award, August 2019

A SBIR Phase II contract was awarded to Orphagen Pharmaceuticals in August, 2019 for $1,093,784.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
National Institutes of Health
National Institutes of Health
SBIR
1R44HD100256-01
Phase II
1,093,784
August 12, 2019
sbir.gov/node/1685111
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award, July 2015

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals in July, 2015 for $224,954.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43CA200076-01
Phase I
224,954
July 1, 2015
sbir.gov/node/1044313
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award, September 2015

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals in September, 2015 for $325,051.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43HL124897-01A1
Phase I
325,051
September 1, 2015
sbir.gov/node/1030727
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $250,507.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43CA163009-01A1
Phase I
250,507
sbir.gov/node/399944
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $218,858.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43DK071461-01
Phase I
218,858
sbir.gov/node/260991
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $499,746.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43CA099875-01A1
Phase I
499,746
sbir.gov/node/260985
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $144,158.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43DK065426-01
Phase I
144,158
sbir.gov/node/260987
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Orphagen Pharmaceuticals for $961,179.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
2R44MH075461-03
Phase II
961,179
sbir.gov/node/261001
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $446,635.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43TR000976-01A1
Phase I
446,635
sbir.gov/node/678394
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $520,358.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43CA150540-01
Phase I
520,358
sbir.gov/node/8401
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $220,839.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43HD068078-01A1
Phase I
220,839
sbir.gov/node/368623
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $223,229.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43DK102221-01A1
Phase I
223,229
sbir.gov/node/705611
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $266,559.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43DK079452-01A1
Phase I
266,559
sbir.gov/node/260999
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $303,596.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43NS059219-01
Phase I
303,596
sbir.gov/node/260995
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $258,166.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43AR055427-01
Phase I
258,166
sbir.gov/node/260997
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $270,181.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43AI060447-01
Phase I
270,181
sbir.gov/node/260989
‌
ORPHAGEN PHARMACEUTICALS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Orphagen Pharmaceuticals for $460,339.0 USD from the U.S. Department of Health & Human Services.

Orphagen Pharmaceuticals
Orphagen Pharmaceuticals
SBIR
1R43MH075461-01
Phase I
460,339
sbir.gov/node/260993
18 results
0 selected
18 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us